Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.285ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.285ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.285NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.582ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.582ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.582ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.582NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.580ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.580ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.580ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.580NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.306ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.306ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.306ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.306NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.280ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.280ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.280ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.280NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.329ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.329ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.329ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.329NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.396ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.396ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.396ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.396NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.595.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
B.1.595.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.595.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.595.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
B.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.311ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.311ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.311ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.311NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.369ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.369ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.369ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.369NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.367ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.367ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.367ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.367NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.595ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.595ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.595ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used